Search

everythinglearnresearchcommunity

for

Search:↓

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Thermal spring waters and their microbes could be good for skin health and treating some skin conditions in skincare products.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Topical treatments led to hair regrowth in a man with linear morphea.

Retinol may affect immune responses in people with frequent skin boils.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.